Financiamento

Financiador: International Association for the Study of Lung Cancer (IASLC)

1 financiamentos - 42.500€

datos dispoñibles desde 2020

2020

Dual Serine/ Threonine and Tyrosine kinase (DSTYK) as a new target for lung cancer therapy and immunotherapy combination
42.500,00